Joseph Edelman – AMLX history
- Issuer:
- AMYLYX PHARMACEUTICALS INC
- Quarters tracked:
- 6 (Q4 2024 → Q1 2026)
- Current shares:
- 8,284,882
- Current value:
- $115.16M
- Peak shares:
- 8,952,365 (Q3 2025)
- Overall change:
- +22%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 8,284,882 | $115.16M | $13.90 | 0 | 0% |
| Q4 2025 | 8,284,882 | $100.08M | $12.08 | -667,483 | -7% |
| Q3 2025 | 8,952,365 | $121.66M | $13.59 | +1,050,000 | +13% |
| Q2 2025 | 7,902,365 | $50.65M | $6.41 | +28,017 | 0% |
| Q1 2025 | 7,874,348 | $27.88M | $3.54 | +1,100,000 | +16% |
| Q4 2024 | 6,774,348 | $25.61M | $3.78 | — | NEW |